| Treatment Stage |
Protocol Title
|
ClinicalTrials.Gov Link
|
Penn Research Coordinator
|
Am I Eligible? |
| Recurrent |
ATRN: A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors |
NCT04905914 |
Andrea Standish, RN |
Eligibility Criteria |
| Recurrent |
A Phase 1/2 Study of CPI-0209 in Patients with Advanced Solid Tumors and Lymphomas |
NCT04104776 |
Destany Fields |
Eligibility Criteria
|
| Recurrent |
First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1047 in subjects with malignant solid tumors |
NCT05180474 |
Katie Hayes, RN |
Eligibility Criteria |
